« Back
Home /
EPOR Blocking Peptide (C-term)

EPOR Blocking Peptide (C-term)

Item no.	ABC-BP20930c
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology By Cell Type Hematology Leukemia Lymphoma Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Winkelmann J.C.,et al.Blood 76:24-30(1990). Jones S.S.,et al.Blood 76:31-35(1990). Noguchi C.T.,et al.Blood 78:2548-2556(1991). Ehrenman K.,et al.Exp. Hematol. 19:973-977(1991). Nakamura Y.,et al.Science 257:1138-1141(1992).
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Erythropoietin receptor,EPO-R,EPOR
Similar products	EPOR, Erythropoietin receptor, EPO-R
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence is selected from aa 470-484 of HUMAN EPOR
Bio Background	Receptor for erythropoietin. Mediates erythropoietin- induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.
Gene Name	EPOR {ECO:0000303\|PubMed:2163695, ECO:0000312\|HGNC:HGNC:3416}
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP20930c-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 10 days

Compare

Add to wishlist

Get an offer